U.S. Electrical Stock News

Labcorp Holdings (LH) is back in focus after reporting second quarter revenue of US$3,731.1 million and net income of US$298.7 million. The company also raised full year 2026 guidance and highlighted new precision oncology and consumer genetic testing offerings. See our latest analysis for Labcorp Holdings. Against this backdrop of new oncology and genetic testing launches, Labcorp Holdings’ share price has gained 8.84% over the past month and 21.56% over the past 90 days, while the 1 year...

In July 2026, Option Care Health reported higher second-quarter sales of US$1,442.4 million and net income of US$53.91 million year over year, confirmed third-quarter guidance for low- to mid-single-digit sequential net revenue growth, updated full-year revenue expectations to US$5.68–US$5.78 billion, continued share repurchases under its January 2025 program, and reiterated that it is actively evaluating acquisitions. An interesting angle for investors is how Option Care Health is balancing...

Over the last 7 days, the United States market has risen by 4.9%, contributing to a 21% increase over the past year, with earnings forecasted to grow by 17% annually. In such an environment, identifying undervalued stocks that offer potential discounts can be a strategic approach for investors seeking opportunities amidst robust market performance.

The United States market has shown robust performance, climbing 4.9% in the last 7 days and up 21% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In such a thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests with shareholders.

Over the last 7 days, the United States market has risen by 4.9%, and over the past year, it is up 21%, with earnings forecasted to grow by 17% annually. In such a robust market landscape, identifying promising stocks requires a keen eye for companies with solid fundamentals and growth potential. Penny stocks, though an older term, still capture the essence of smaller or emerging companies that can offer significant opportunities; in this article, we explore three such stocks that combine...

In late July 2026, FactSet Research Systems Inc. expanded its long-running relationship with RepRisk AG by naming it the preferred partner for providing sustainable investing and business conduct risk data across multiple delivery channels and investment workflows. This deeper integration of RepRisk’s ESG intelligence into FactSet’s platform could strengthen how clients embed business conduct risk analysis into research, portfolio management, and stewardship processes. We'll now examine...

Federated Hermes (FHI) has drawn fresh attention after reporting second quarter 2026 results that surpassed analyst expectations, along with continued investment in private markets and digital asset management initiatives highlighted by management. See our latest analysis for Federated Hermes. For context, Federated Hermes shares trade at US$64.96, with a 1 month share price return of 14.8% and a year to date share price return of 24.0%. The 3 year total shareholder return of 120.7% points to...

Tariff headlines are back in focus after 25 U.S. states moved to challenge the latest Section 301 global duties, and that legal fight could matter a lot for import heavy consumer stocks. When tariffs sit in limbo, pricing power, margins, and inventory planning all come under the microscope. Some companies may face pressure if costs stay elevated, while others could gain flexibility if duties are rolled back or refunded. This article walks through 3 stocks that appear positioned to potentially...

New global tariffs of 10% to 12.5% on nearly all U.S. imports are creating fresh questions for domestic manufacturing stocks. With 25 states, including New Jersey, challenging the policy in court and seeking refunds on tariffs already paid, the eventual outcome could reshape costs, supply chains, and pricing power for many U.S. producers. For investors, this is less about predicting the lawsuit and more about understanding which companies might be better positioned if import costs stay...

Dividend Fortresses focuses on stocks that aim to combine stability with dividend yields above 5%. That theme can appeal if you want income that may help offset the impact of changing inflation trends, shifting interest rate expectations and uneven growth signals across regions. Recent data on services strength, softer inflation pressures and more measured central bank moves gives fresh context for high yield, resilient dividend payers. In this article you will see three of the strongest...

Hexcel Corporation recently reported past second-quarter 2026 results, posting sales of US$1,058.6 million and net income of US$98.6 million, and the board declared a regular quarterly dividend of US$0.18 per share payable in August 2026. Alongside stronger earnings and higher first-half profits than a year earlier, Hexcel raised its full-year 2026 sales guidance to US$2.025–2.125 billion and confirmed completion of its prior share repurchase program. We’ll now examine how Hexcel’s raised...

Fresh sanctions between the US and China are putting supply chains, technology access, and overseas revenue in the spotlight for US industrial automation and robotics stocks. Some companies could see new interest as investors look at potential reshoring, while others may face questions about exposure to restricted markets or components. This article focuses on three stocks from our US Industrial Automation & Robotics Stocks screener that appear more directly exposed to the latest trade...

On 4 August 2026, LegalZoom.com, Inc. announced it had launched an agent integrated with Microsoft 365 Copilot, bringing its business formation, compliance filing, and attorney consultation services directly into the Copilot environment via the Microsoft Marketplace. This move embeds LegalZoom’s legal support tools inside the everyday productivity workflows of many small businesses, potentially deepening usage of its services and reinforcing its positioning within AI-enabled business...

Why Ameren’s latest earnings matter for investors Ameren (AEE) has come into focus after its recent second quarter earnings report, where net income and earnings per share rose even as revenue declined, and management reaffirmed full year 2026 earnings guidance. See our latest analysis for Ameren. Ameren’s share price has eased over the past month, with a 30 day share price return of 4.85% and a 7 day share price return of a 2.73% decline, even as options activity and reaffirmed 2026 guidance...

Why CVR Energy’s latest earnings and dividend matter for investors CVR Energy (CVI) has drawn investor attention after releasing second quarter 2026 results along with a fresh dividend declaration. The company reported higher sales year over year and a sharply reduced net loss, while affirming a quarterly cash payout. See our latest analysis for CVR Energy. CVR Energy’s share price has climbed 32.31% year to date and sits at US$33.33, with a 17.03% 1 month share price return suggesting...

In the second quarter ended June 30, 2026, O-I Glass, Inc. reported sales of US$1,668 million, a net loss of US$972 million largely driven by an US$873 million goodwill impairment, and also confirmed that no shares were repurchased in the April–June 2026 period under its existing buyback plan. These results mark a sharp deterioration in reported profitability compared with the prior year, raising fresh questions about the value of past acquisitions and the balance between returning capital...

What the latest quarter means for Cincinnati Financial stock The latest move in Cincinnati Financial (CINF) has been driven by its second quarter earnings, which combined higher revenue and profit with management comments about catastrophe losses and pricing in a softer property casualty market. See our latest analysis for Cincinnati Financial. At a share price of $179.42, Cincinnati Financial has given investors a 90 day share price return of 11.84% and a 1 year total shareholder return of...

Chimera Investment Corporation has reported past second-quarter 2026 results showing net income of US$17.37 million, down from US$35.45 million a year earlier, alongside a swing to a basic loss per share of US$0.05 from basic earnings per share of US$0.17, while also declaring third-quarter 2026 cash dividends on all four series of its preferred stock. What stands out is the contrast between weaker profitability, including a six‑month net loss of US$26.54 million versus prior net income of...

Dividend increase puts Encompass Health in focus Encompass Health (EHC) has drawn fresh attention after lifting its quarterly dividend to US$0.21 per share, with payment scheduled for October 15, 2026, and an ex dividend date of October 1. See our latest analysis for Encompass Health. Despite the dividend headline, Encompass Health’s recent share price return has been mixed, with the stock down over the past week but posting a positive 90 day share price return and strong multi year total...

In the second quarter of 2026, Hinge Health reported revenue of US$212.82 million and net income of US$43.69 million, a sharp turnaround from a very large net loss a year earlier, and raised both its full-year and third-quarter 2026 revenue guidance. The company also expanded its share repurchase authorization to US$550 million and has completed US$196.50 million of buybacks, while agreeing to acquire Cylinder Health to move beyond musculoskeletal care into gastrointestinal services. We’ll...

With gold prices extending gains, the dollar softer and oil cheaper, investors are getting a reminder that inflation and interest rate expectations can shift quickly. That mix is pushing some to look again at consumer staples, where large, essential product companies can sometimes hold up better when the macro picture is uncertain. This article focuses on inflation resilient consumer staples stocks and how they are exposed to the latest moves in safe haven demand, rate hike odds and...

1st Source (SRCE) stock traders are reacting to the company’s second quarter 2026 update, which reported higher net interest income and net income, a dividend increase, and lower net charge-offs. See our latest analysis for 1st Source. The latest earnings and dividend news has arrived against a strong backdrop for 1st Source, with the stock’s share price returning 10.29% over the past month and 45.41% year to date. Three and five year total shareholder returns of 103.65% and 115.17% suggest...

Beam Therapeutics (BEAM) reported second quarter 2026 results that showed a wider net loss and higher loss per share, which has become a key focus for investors assessing the stock this week. See our latest analysis for Beam Therapeutics. Despite the wider quarterly loss, Beam Therapeutics has seen a sharp 1 day share price return of 9.42% and a 7 day share price return of 7.84%. However, the 30 day share price return is down 18.51% and the 90 day share price return is down 12.34%. At the...

The recent pullback in Novo Nordisk stock after its guidance update has put a harsh spotlight on obesity and metabolic disorder therapeutics. The market reaction underscored how sensitive investors are to clinical data, pipeline clarity, and competitive pressure from Eli Lilly’s obesity drugs. For you, this creates a chance to reassess exposure to companies tied to the same theme. This article looks at three stocks from our Healthcare, Obesity and Metabolic Disorder Therapeutics screener that...